A collaborative drug therapy management agreement shall include:
- (1) The types of prescriptive authority decisions the pharmacist may make (e.g., initiation, continuation or modification);
- (2) Patients who are eligible for treatment;
- (3) The types of diseases, drugs, or drug categories involved (there are no limitations on disease states or conditions);
- (4) The procedures, decision criteria, plans, or guidelines the pharmacist is to follow when making therapeutic decisions, particularly when initiating or modifying drug therapy;
- (5) Required training;
- (6) A plan for periodic review, feedback and quality assurance; and
- (7) Procedures for documenting prescribing decisions.
(Effective January 2, 2013)